Use of adjuvant trastuzumab in women with human epidermal growth factor receptor 2 (HER2)-positive breast cancer by race/ethnicity and education within the National Comprehensive Cancer Network.
All Authors:
Freedman RA, Hughs ME, Otteson RA, et al.
Author Profiles:
Nancy L. Keating
Publish Date:
Journal:
Cancer